Target intelligence / Profile preview

Enteroendocrine L-cell nutrient sensing pathways

Molecular classification
G protein-coupled receptor, Transporter, Ion channel, Signaling pathway
01

Overview

Enteroendocrine L-cell nutrient sensing pathways represent the integrated molecular systems through which specialized intestinal cells detect dietary intake and regulate metabolic homeostasis [2, 3]. These pathways involve a diverse array of sensors, including G protein-coupled receptors (GPCRs) such as GPR119, FFAR1 (GPR40), FFAR4 (GPR120), and TGR5 (GPBAR1), as well as nutrient transporters like the sodium-glucose co-transporter 1 (SGLT1) [2, 4]. Upon activation by luminal nutrients—including glucose, long-chain fatty acids, and amino acids—these sensors trigger intracellular signaling cascades that lead to the secretion of the incretin hormones glucagon-like peptide-1 (GLP-1) and peptide YY (PYY) [4, 5]. These hormones are vital for enhancing glucose-dependent insulin secretion, slowing gastric emptying, and promoting satiety [2, 4]. Dysregulation of these sensing mechanisms is a hallmark of metabolic disorders such as type 2 diabetes and obesity, where the postprandial incretin response is often blunted [1, 2]. Pharmacological strategies targeting these pathways, such as GPR119 agonists or TGR5 modulators, aim to restore or enhance endogenous hormone release to improve glycemic control and support weight management [2, 4]. This approach offers a potential therapeutic alternative to exogenous GLP-1 receptor agonists by leveraging the body's natural hormone production mechanisms [2].

Other names
L-cell nutrient sensingIncretin secretion pathwaysGut nutrient sensing mechanismsEnteroendocrine nutrient sensing
02

Mechanism of action

Activation of G protein-coupled receptors (GPR119, FFAR1, FFAR4, TGR5) and nutrient transporters (SGLT1) on the L-cell membrane, triggering intracellular signaling (cAMP, Ca2+) that leads to the exocytosis of GLP-1 and PYY [2, 4].

03

Biological functions

Signal transductionHormone secretionMetabolic regulationAppetite regulationGlucose homeostasis
04

Disease associations

Type 2 diabetesObesityMetabolic syndromeInflammatory bowel disease
05

Safety considerations

Gastrointestinal side effects (nausea, diarrhea)Gallbladder contraction (TGR5 agonists)Pruritus (TGR5 agonists)Potential for hypoglycemia in combination therapy
06

Interacting drugs

MBX-2982

7 more in the full profile.

07

Biomarkers

Plasma GLP-1Plasma PYYPostprandial glucoseInsulin secretion rateGastric emptying rate

Beyond the preview

Go deeper on Enteroendocrine L-cell nutrient sensing pathways.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Enteroendocrine L-cell nutrient sensing pathways.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call